elekta - novamedtech.senovamedtech.se/wp-content/uploads/2012/09... · 1950-2000 2000-2011 maximize...
TRANSCRIPT
![Page 1: Elekta - novamedtech.senovamedtech.se/wp-content/uploads/2012/09... · 1950-2000 2000-2011 Maximize dose to tumor „ Avoid adjacent critical structures „ High quality, efficient](https://reader033.vdocument.in/reader033/viewer/2022051808/600dad35cdad043a6105013b/html5/thumbnails/1.jpg)
ElektaResearch and global business development
Sören Johansson, Vice President, Business development
![Page 2: Elekta - novamedtech.senovamedtech.se/wp-content/uploads/2012/09... · 1950-2000 2000-2011 Maximize dose to tumor „ Avoid adjacent critical structures „ High quality, efficient](https://reader033.vdocument.in/reader033/viewer/2022051808/600dad35cdad043a6105013b/html5/thumbnails/2.jpg)
Radi Medical / St Jude
Nobel Biocare
Mikromekanisk trycksensor
Titanimplantat
Entific / CochlearHörselimplantat
Hjärt-lungmaskiner
Strålkniven
Radioterapi
Dialysutrustningen
AGA
Gambro
Elekta
Ett historiskt perspektiv- från Innovation till Industri
Ett resultat av ett nära
samarbete mellan industri,
akademi och sjukvården
![Page 3: Elekta - novamedtech.senovamedtech.se/wp-content/uploads/2012/09... · 1950-2000 2000-2011 Maximize dose to tumor „ Avoid adjacent critical structures „ High quality, efficient](https://reader033.vdocument.in/reader033/viewer/2022051808/600dad35cdad043a6105013b/html5/thumbnails/3.jpg)
Operation och sårbehandling
Infektionskontroll, kirurgi
och intensivvård
Implantat, urologi, kirurgi och
andningshjälpmedel
IT lösningar i sjukvården
Digital röntgen
Getinge
Mölnlycke Health Care
Astra Tech
Cambio
Sectra
Ett historiskt perspektiv- från Innovation till Industri
Pacemakern Siemens Elema / St Jude
![Page 4: Elekta - novamedtech.senovamedtech.se/wp-content/uploads/2012/09... · 1950-2000 2000-2011 Maximize dose to tumor „ Avoid adjacent critical structures „ High quality, efficient](https://reader033.vdocument.in/reader033/viewer/2022051808/600dad35cdad043a6105013b/html5/thumbnails/4.jpg)
Elekta – one of the fastest growing companies in radiation therapy
• Every year over 1,000,000 patients benefit from treatment with radiation therapy equipment from Elekta
• One of the fastest growing companies in the radiation therapy field
• Close to 3,400 employees worldwide*
• Net sales SEK 9.0 bn, operating result SEK 1.8 bn, margin 20%
• Headquarters in Stockholm, Swedenoffices in about 40 countries
* Incl. acquisition of Nucletron
![Page 5: Elekta - novamedtech.senovamedtech.se/wp-content/uploads/2012/09... · 1950-2000 2000-2011 Maximize dose to tumor „ Avoid adjacent critical structures „ High quality, efficient](https://reader033.vdocument.in/reader033/viewer/2022051808/600dad35cdad043a6105013b/html5/thumbnails/5.jpg)
Strong growth with increased profitability
Net Sales EBITSEK M SEK M
![Page 6: Elekta - novamedtech.senovamedtech.se/wp-content/uploads/2012/09... · 1950-2000 2000-2011 Maximize dose to tumor „ Avoid adjacent critical structures „ High quality, efficient](https://reader033.vdocument.in/reader033/viewer/2022051808/600dad35cdad043a6105013b/html5/thumbnails/6.jpg)
Cancer incidence is growing
0,4
0,4
0,4
0,5
0,5
0,7
0,9
1,0
1,2
1,4
1,6
0,0 0,5 1,0 1,5
Leukaemia
Non-Hodgkin …
Bladder
Oesophagus
Cervix uteri
Liver
Prostate
Stomach
Colorectum
Breast
Lung
12,713,3
15,0
16,9
19,1
21,4
0
5
10
15
20
25
2008 2010 2015E 2020E 2025E 2030E
Million
Most frequent cancersCancer incidence
Source: Globocan 2008
Number of new cancer cases per year (millions, 2008)
2010A 2030E
World population:
Population +60 years, world:
7.0 bn
760 M
8.3 bn
1.4 bn+82%
+20%
Age group +60 years will
grow at the highest pace
Approx. 60 percent* of all new cancer
cases occur in age group +60 years
![Page 7: Elekta - novamedtech.senovamedtech.se/wp-content/uploads/2012/09... · 1950-2000 2000-2011 Maximize dose to tumor „ Avoid adjacent critical structures „ High quality, efficient](https://reader033.vdocument.in/reader033/viewer/2022051808/600dad35cdad043a6105013b/html5/thumbnails/7.jpg)
Från innovation till generisk utveckling
Medicinteknik är “applied science”; nya upptäckter inte
nödvädigt för att utveckla nya och viktiga lösningar –
“Generisk FoU”
Precision Radiation Therapy
Image Guided Radiation Therapy
StereotacticRadiation Therapy
Gamma Knife®
surgery
Volumetric Modulated Arc therapy
![Page 8: Elekta - novamedtech.senovamedtech.se/wp-content/uploads/2012/09... · 1950-2000 2000-2011 Maximize dose to tumor „ Avoid adjacent critical structures „ High quality, efficient](https://reader033.vdocument.in/reader033/viewer/2022051808/600dad35cdad043a6105013b/html5/thumbnails/8.jpg)
Measurements
Analysis
Knowledge
Wisdom
Information
”Today & tomorrow”• Complex solutions• Clinical solutions• Organisational impact• Internationalization• High commercialisation costs
”The old days”• ”Simple” solutions• Direct to end-user• Not so expensive to commercialise
”From treatment and system to disease management”
![Page 9: Elekta - novamedtech.senovamedtech.se/wp-content/uploads/2012/09... · 1950-2000 2000-2011 Maximize dose to tumor „ Avoid adjacent critical structures „ High quality, efficient](https://reader033.vdocument.in/reader033/viewer/2022051808/600dad35cdad043a6105013b/html5/thumbnails/9.jpg)
Technology as a facilitator for a changing practice….
1950-2000 2000-2011
Maximize dose to tumor
„
Avoid adjacent critical structures
„
High quality, efficient delivery
„
Todays objectives
1. Solutions for effective radiotherapy
2. Workflow
3. Efficiency
4. Simplicity
![Page 10: Elekta - novamedtech.senovamedtech.se/wp-content/uploads/2012/09... · 1950-2000 2000-2011 Maximize dose to tumor „ Avoid adjacent critical structures „ High quality, efficient](https://reader033.vdocument.in/reader033/viewer/2022051808/600dad35cdad043a6105013b/html5/thumbnails/10.jpg)
Disease pathways
Comprehensive solutions
Technology
Solutions
Evolution of Elekta’s role in cancer care
• Elekta Lung Research Group
• Elekta Clarity®
consortium
• Elekta Spine consortium
• Leksell GammaKnife® Society
• AgilityTM
• VMAT
• MOSAIQ® RTP
• Flexitron solution• IMRT
• IGRT
• Disease management
• Full offering
• Data management - informatics
• More service and upgrades
![Page 11: Elekta - novamedtech.senovamedtech.se/wp-content/uploads/2012/09... · 1950-2000 2000-2011 Maximize dose to tumor „ Avoid adjacent critical structures „ High quality, efficient](https://reader033.vdocument.in/reader033/viewer/2022051808/600dad35cdad043a6105013b/html5/thumbnails/11.jpg)
*Net sales, rounded figures
Emerging markets
Leadership and strong growth
• Invest ahead of the curve
• Focus on training and education
• Product development specialized for emerging markets
70%
30%
2011/12
80%
20%
2004/05
Emerging markets Mature markets
60%
40%
2014/15E
![Page 12: Elekta - novamedtech.senovamedtech.se/wp-content/uploads/2012/09... · 1950-2000 2000-2011 Maximize dose to tumor „ Avoid adjacent critical structures „ High quality, efficient](https://reader033.vdocument.in/reader033/viewer/2022051808/600dad35cdad043a6105013b/html5/thumbnails/12.jpg)
Elekta has strong performance in emerging markets
No. 1No. 1
No.1(shared)
No. 1
*Excl. Nucletron CAGR is 22%
1,3
1,9
2,2
2,6
08/09 09/10 10/11 11/12
Elekta emerging markets
Net sales, SEK bn
CAGR
26%*
![Page 13: Elekta - novamedtech.senovamedtech.se/wp-content/uploads/2012/09... · 1950-2000 2000-2011 Maximize dose to tumor „ Avoid adjacent critical structures „ High quality, efficient](https://reader033.vdocument.in/reader033/viewer/2022051808/600dad35cdad043a6105013b/html5/thumbnails/13.jpg)
Innovation through collaboration
![Page 14: Elekta - novamedtech.senovamedtech.se/wp-content/uploads/2012/09... · 1950-2000 2000-2011 Maximize dose to tumor „ Avoid adjacent critical structures „ High quality, efficient](https://reader033.vdocument.in/reader033/viewer/2022051808/600dad35cdad043a6105013b/html5/thumbnails/14.jpg)
Clinical Residency Training (Eur)
Key
R&D and Clinical Training
Collaboration with leading clinical centersCenters of Excellence
NKI-AVL, AmsterdamIGRT/4D Clinical Program
SPI/Swedish Hospital, SeattleIGRT/VMAT Clinical Program
Princess Margaret Hospital, TorontoIGRT Clinical Program
Wurzburg University ClinicSRT Clinical Program
Mannheim University ClinicIMRT / VMAT Clinical Program
EMR / MOP Clinical Program
William Beumont Hospital, Detroit
UPMC, PittsburghSRS
Tokyo University Hospital
KS, StockholmSRS
• Partners in R&D
• Workflow
• Clinical publications
• Financial feasibility
• Risk assessment
• Regulatory demand
UMC, UtrechtIGRT Clinical Program
BNI – Beijing
Western China Univ – Huaxi
![Page 15: Elekta - novamedtech.senovamedtech.se/wp-content/uploads/2012/09... · 1950-2000 2000-2011 Maximize dose to tumor „ Avoid adjacent critical structures „ High quality, efficient](https://reader033.vdocument.in/reader033/viewer/2022051808/600dad35cdad043a6105013b/html5/thumbnails/15.jpg)
Sverige som bas för en medicinteknisk företagsutveckling
1. Det svenska sjukvårdssystemet har en bra vision, det krävs dock en kontinuerlig klinisk utveckling inom sjukvården för att bibehålla ledarskap
2. Det finns ett behov att balansera pragmatisk leverans av vård med forskning och klinisk utveckling för att utveckla patientvården
3. Vår sjukvårdsfinansiering har skapat felaktiga drivkrafter på avdelningsnivå - budgetsystem kontrollerar kostnader utan att belöna förbättrad ”outcome”
4. Svaghet i beslutsfattande och auktoritet vid implementering av förändringar inom sjukvårdsorganisationen
5. Sjukvården i Sverige saknar insikten att industrin är en viktig partner till dem i arbetet att utveckla densamma
6. Industrin är ej en passiv intressent.
![Page 16: Elekta - novamedtech.senovamedtech.se/wp-content/uploads/2012/09... · 1950-2000 2000-2011 Maximize dose to tumor „ Avoid adjacent critical structures „ High quality, efficient](https://reader033.vdocument.in/reader033/viewer/2022051808/600dad35cdad043a6105013b/html5/thumbnails/16.jpg)
Förutsättningar för samverkan industri-sjukvård
• Attityd
– Transparens samt öppenhet att
se industrin som en partner i
arbetet att utveckla sjukvården
– Skapa en gemensam vision av
ett partnerskap där industrin
samt sjukvården samarbetar för
att utveckla en kostnadseffektiv
sjukvård
![Page 17: Elekta - novamedtech.senovamedtech.se/wp-content/uploads/2012/09... · 1950-2000 2000-2011 Maximize dose to tumor „ Avoid adjacent critical structures „ High quality, efficient](https://reader033.vdocument.in/reader033/viewer/2022051808/600dad35cdad043a6105013b/html5/thumbnails/17.jpg)
Förutsättningar för samverkan industri-sjukvård
• Budget och organisation
– Sjukvården bör skapa ekonomiskt
samt organisatoriskt utrymme som
möjliggör samverkan med industrin
samt tydliga ledningsformer och
spelregler
– Förändrad syn på hur
upphandlingsregler tillämpas i
samverkansprojekt och
innovationsupphandling
![Page 18: Elekta - novamedtech.senovamedtech.se/wp-content/uploads/2012/09... · 1950-2000 2000-2011 Maximize dose to tumor „ Avoid adjacent critical structures „ High quality, efficient](https://reader033.vdocument.in/reader033/viewer/2022051808/600dad35cdad043a6105013b/html5/thumbnails/18.jpg)
Elekta R&D in Sweden- conditions for collaboration with academia in Sweden
• Strong internal R&D in Sweden
– 150% organic growth since the year 2000
– Now around 80 engineers in Stockholm, working in close collaboration with other Elekta R&D centers globally
– Recent addition of 35 engineers in Uppsala (Nucletronacquisition)
• Swedish R&D is internationally competitive
– Excellent supply of competence– Example: Recent recruitment of one Research Engineer to Elekta
Stockholm resulted in 100+ qualified applicants, out of which more than 40 had Ph.D. degrees
– Several Swedish universities have started Master programs in Medical Engineering
– Creativity and problem-solving mindset
– Straight communication and transparency
– Reasonable cost structure
![Page 19: Elekta - novamedtech.senovamedtech.se/wp-content/uploads/2012/09... · 1950-2000 2000-2011 Maximize dose to tumor „ Avoid adjacent critical structures „ High quality, efficient](https://reader033.vdocument.in/reader033/viewer/2022051808/600dad35cdad043a6105013b/html5/thumbnails/19.jpg)
Elekta Research & Development Sites
Crawley(Oncology)
Stockholm(Neuro)
Helsinki(Neuro)
Atlanta(Treatment planning)
Sunnyvale(Information systems)
Schwabmünchen(Oncology)
Beijing(Oncology)
Milano(Oncology)
St Louis(Treatment planning)
Product development
driven by customer needs,
in close collaboration with
leading centers worldwide
Shanghai(RTP/Neuro)
Montreal(US imaging)
Uppsala(Brachy, RTP)
Veenendaal(Brachy)
June 2012
![Page 20: Elekta - novamedtech.senovamedtech.se/wp-content/uploads/2012/09... · 1950-2000 2000-2011 Maximize dose to tumor „ Avoid adjacent critical structures „ High quality, efficient](https://reader033.vdocument.in/reader033/viewer/2022051808/600dad35cdad043a6105013b/html5/thumbnails/20.jpg)
Research collaboration with hospitalsIndustry perspective
• Access to clinical expertise is a key success factor for developing innovative products
• From the industry perspective, an ideal partner has:
– Established scientific leadership in the relevant area
– Access to additional funding (hospital, regional, national, international)
– A shared vision and passion to create innovative and cost efficient healthcare solutions
• Geographical proximity helps but is not a requirement
Elekta has many active clinical and technical collaborations with
hospitals and universities around the world, but most large projects
are outside Sweden
![Page 21: Elekta - novamedtech.senovamedtech.se/wp-content/uploads/2012/09... · 1950-2000 2000-2011 Maximize dose to tumor „ Avoid adjacent critical structures „ High quality, efficient](https://reader033.vdocument.in/reader033/viewer/2022051808/600dad35cdad043a6105013b/html5/thumbnails/21.jpg)
Ongoing research collaborations in Sweden
Swedish partners Project
Linköping University, Lund University,
Linköping University Hospital
• Fluorescence spectroscopy for neurosurgery
Karolinska Hospital • Narrow beam dosimetry and Monte Carlo simulations
• Leksell Gamma Knife treatment planning (M.Sc. project)
• Stereotactic radiotherapy
Chalmers University of Technology
(VINN Excellence Centre Chase)
• Hyperthermia for head and neck cancer
Chalmers University of Technology
(EU project with 13 partners)
• Hybrid MEG-MRI Imaging System
Uppsala University Hospital
CTMH, Stockholm
CMIV, Linköping
• Radiotherapy planning
• ”Clinical Innovation Fellowship”, Team Onkologi
• industridoktorandbidrag ?? VR, ”Avancerade MR-metoder för
funktionell och stereotaktisk neurokirurgi”
![Page 22: Elekta - novamedtech.senovamedtech.se/wp-content/uploads/2012/09... · 1950-2000 2000-2011 Maximize dose to tumor „ Avoid adjacent critical structures „ High quality, efficient](https://reader033.vdocument.in/reader033/viewer/2022051808/600dad35cdad043a6105013b/html5/thumbnails/22.jpg)
1. Nyföretagande vs utveckling av etablerat företag
2. Nya innovationer vs Vidareutveckling av befintliga produkter
3. Akademisamarbeten vs Kliniksamarbeten
4. Akademi och Industri har samma behov och mål
– Ledarskap
– Excellence
– Competence
– Behov av samverkan (Industri – akademi)
– Tillgång till sjukvård och klinik